Robert J. Adelman, 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 32,095 shares at $21.30 ($731K) on 2020-02-28, disclosed to the SEC on 2020-03-03.
Open-market sale of $731k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.30 | 5,100 | $109K | 14.9% |
| 2 | $23.06 | 10,297 | $237K | 32.5% |
| 3 | $23.06 | 10,297 | $237K | 32.5% |
| 4 | $23.00 | 6,401 | $147K | 20.1% |
| Total | $22.77 avg | 32,095 | $731K | 100% |
| Filing → |
| AKRO | SELL | 2020-01-06 | $1.4M | — | Filing → |
| ARYX | BUY | 2007-11-14 | $3.0M | — | Filing → |